Detalhe da pesquisa
1.
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer.
J Cell Mol Med
; 24(5): 3117-3127, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032474
2.
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
Int J Mol Sci
; 21(23)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33261142
3.
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Cell Oncol (Dordr)
; 43(3): 431-444, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166583
4.
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer.
Cancer Lett
; 491: 50-59, 2020 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735909
5.
Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models.
ACS Omega
; 4(8): 13005-13014, 2019 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31460427
6.
Transcriptome evolution from breast epithelial cells to basal-like tumors.
Oncotarget
; 9(1): 453-463, 2018 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416627
7.
Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers.
Sci Rep
; 7(1): 17530, 2017 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235520
8.
DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer.
Oncotarget
; 8(38): 62834-62841, 2017 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968952
9.
Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors.
Oncotarget
; 8(12): 19478-19490, 2017 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28061448
10.
Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer.
Mol Cancer Ther
; 16(11): 2552-2562, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28847989
11.
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.
Oncotarget
; 8(13): 21733-21740, 2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423514
12.
In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment.
Mol Cancer Ther
; 15(8): 1823-33, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256375
13.
Circulating DNA and Survival in Solid Tumors.
Cancer Epidemiol Biomarkers Prev
; 25(2): 399-406, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604269
14.
Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.
Oncotarget
; 6(31): 31272-83, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26418718
15.
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses.
Oncotarget
; 6(37): 39538-49, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446908
16.
Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer.
Oncotarget
; 6(29): 27923-37, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26314846
17.
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.
PLoS One
; 9(4): e95219, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777052